This is an old revision of the document!
Emergent BioSolutions
Emergent BioSolutions is an American multinational biopharmaceutical company based in Gaithersburg, Maryland.
COVID-19
In June 2020, AstraZeneca and Emergent partnered to manufacture their COVID-19 vaccine product.1) 2) In July 2020, Emergent was awarded a five-year contract with Johnson & Johnson to manufacture a core component of their COVID-19 vaccine product.3)
1)
Blankenship, K. (2020, June 11). AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine. FiercePharma. https://archive.ph/I1uKJ
2)
Neri, M. B. (2020, June 11). Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for AstraZeneca’s COVID-19 Vaccine Candidate. Emergent BioSolutions. https://archive.ph/ivKBp
3)
Knapp, A. (2021, March 1). Little-Known Publicly Traded Company Given Massive Deal To Manufacture One-Shot Covid-19 Vaccine. Forbes. https://archive.ph/FCx7o